Matches in Nanopublications for { ?s ?p ?o <http://rdf.disgenet.org/nanopublications.trig#NP173781.RAdL00NvdS-lprXaFni5-f-5cxNfte5aQyRX1ZOFgrTew130_provenance>. }
Showing items 1 to 9 of
9
with 100 items per page.
- source_evidence_literature type ECO_0000212 NP173781.RAdL00NvdS-lprXaFni5-f-5cxNfte5aQyRX1ZOFgrTew130_provenance.
- source_evidence_literature label "DisGeNET evidence - LITERATURE" NP173781.RAdL00NvdS-lprXaFni5-f-5cxNfte5aQyRX1ZOFgrTew130_provenance.
- source_evidence_literature comment "Gene-disease associations inferred from text-mining the literature." NP173781.RAdL00NvdS-lprXaFni5-f-5cxNfte5aQyRX1ZOFgrTew130_provenance.
- NP173781.RAdL00NvdS-lprXaFni5-f-5cxNfte5aQyRX1ZOFgrTew130_assertion description "[Also, we found that secreted factors overexpressed by anti-VEGF treatment-resistant pancreatic cancer cells acted in an autocrine manner to induce epithelial-to-mesenchymal transition (EMT) and were thus responsible for increased aggressiveness of bevacizumab-resistant pancreatic tumors.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP173781.RAdL00NvdS-lprXaFni5-f-5cxNfte5aQyRX1ZOFgrTew130_provenance.
- NP173781.RAdL00NvdS-lprXaFni5-f-5cxNfte5aQyRX1ZOFgrTew130_assertion evidence source_evidence_literature NP173781.RAdL00NvdS-lprXaFni5-f-5cxNfte5aQyRX1ZOFgrTew130_provenance.
- NP173781.RAdL00NvdS-lprXaFni5-f-5cxNfte5aQyRX1ZOFgrTew130_assertion SIO_000772 21737511 NP173781.RAdL00NvdS-lprXaFni5-f-5cxNfte5aQyRX1ZOFgrTew130_provenance.
- NP173781.RAdL00NvdS-lprXaFni5-f-5cxNfte5aQyRX1ZOFgrTew130_assertion wasDerivedFrom befree-20140225 NP173781.RAdL00NvdS-lprXaFni5-f-5cxNfte5aQyRX1ZOFgrTew130_provenance.
- NP173781.RAdL00NvdS-lprXaFni5-f-5cxNfte5aQyRX1ZOFgrTew130_assertion wasGeneratedBy ECO_0000203 NP173781.RAdL00NvdS-lprXaFni5-f-5cxNfte5aQyRX1ZOFgrTew130_provenance.
- befree-20140225 importedOn "2014-02-25" NP173781.RAdL00NvdS-lprXaFni5-f-5cxNfte5aQyRX1ZOFgrTew130_provenance.